ARCHIVES

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

This article is from The Cancer Letter archive.

Vol. 18 No. 15 | April 10, 1992

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Funding Mechanisms: How They Are Used

August 12, 1983

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014